98 results on '"Fallani, S."'
Search Results
2. Caspofungin PK in critically ill patients after the first and fourth doses: suggestions for therapeutic drug monitoring?
3. Moxifloxacin concentrations in plasma and tonsillar tissue in adult patients: P1103
4. Cephalosporins: a pharmacological update
5. Erratum: Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients (Journal of Antimicrobial Chemotherapy (2006) vol. 57 (789-792))
6. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot
7. Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report
8. Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukaemia: a pilot study of a monocentric experience
9. Development and evaluation of conventional and PEGylated curcumin liposomes, absorption and tissue distribution studies in mice
10. P4 In vivo evaluation of mutant selection window (MSW) of quinolones against P. aeruginosa strains in thigh infection model
11. Clinical Efficacy and Tolerability of Caspofungin in a Renal Transplant Patient withAspergillus flavusLung Infection: Case Report
12. Intraoperative Positive Fluid Balance Improves Tissue Diffusion of Ceftizoxime
13. In VivoPharmacodynamic Evaluation of Clarithromycin in Comparison to Erythromycin
14. Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics
15. Cefodizime in Skin Suction Blister Fluid and Serum Following a Single Intravenous or Intramuscular Dose in Adult Patients
16. Clinical pharmacokinetics of meropenem after the first and tenth intramuscular administration
17. In VitroPostantibiotic Effect and Postantibiotic Leukocyte Enhancement of Tobramycin
18. Pharmacokinetics and Blister Fluid Penetration of Brodimoprim in Adults
19. In Vitro Effects of Brodimoprim on Human Polymorphonuclear Leukocyte Functions. Preliminary Results
20. Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration
21. Phannacokinetics of azithromycin in patients with impaired hepatic function
22. Ofloxacin concentrations in human inflamed pericoronal tissue after oral administration
23. Azithromycin Concentrations in Serum and Bronchial Secretions of Patients with Cystic Fibrosis.
24. Modulation of neutrophils functions by a beta-interferon of human origin
25. Modulation of neutrophil functions by a beta-interferon of human origin
26. Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment
27. Amoxicillin/clavulanate in chronic rhinosinusitis: Tissue and serum distribution
28. Postantibiotic effect and postantibiotic leukocyte enhancement of fleroxacin compared to ciprofloxacin on [formula omitted] and [formula omitted] strains
29. B. Subtilis spores as a natural pro-host agent in children suffering from recurrent respiratory tract infectious diseases
30. Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis.
31. Treatment for COVID-19: An overview.
32. Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.
33. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
34. Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.
35. Posaconazole oral suspension primary prophylaxis in acute leukemia and allogeneic stem cell transplant patients: can it be used without measurement of plasma concentration?
36. Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate.
37. Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections.
38. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary?
39. Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.
40. Candida glabrata prosthetic hip infection.
41. Daptomycin serum levels in critical patients undergoing continuous renal replacement.
42. Rapid and sensitive LC-MS/MS method for the analysis of antibiotic linezolid on dried blood spot.
43. Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer.
44. Ertapenem peritoneal fluid concentrations in adult surgical patients.
45. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
46. Maintenance of therapeutic concentrations of caspofungin after temporary treatment interruption (48 hours) in a child with invasive aspergillosis.
47. Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants.
48. Clinical efficacy and tolerability of caspofungin in a renal transplant patient with Aspergillus flavus lung infection: case report.
49. Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
50. Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.